Stock Market Watch

ANTEL MEDICAL – Stock split reflects confidence in the future operating results

by ·


ANTEL MEDICAL CORP. (NYSE:CMN) announced today that its Board of Directors has declared a 3-for-2 stock split to be effected as a stock dividend of three shares for each two shares issued and outstanding, payable Wednesday, February 1, 2012 to the holders of record of Cantel’s common stock as of the close of business on Monday, January 23, 2012.  The Company will make cash payments based upon the closing price of Cantel’s shares on the record date in lieu of the issuance of fractional shares.

Andrew A. Krakauer, President and CEO, said, “The stock split reflects our confidence in the future operating results and cash flows of the Company, as well as our ongoing determination to build long-term shareholder value. The stock split will increase the float and provide greater liquidity for shareholders.”

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for the transport and temperature regulation of infectious and biological specimens.


Cantel Medical Corp (Cantel) is a provider of infection prevention and control products and services in the healthcare market. Cantel operates in seven segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Therapeutic Filtration, Specialty Packaging and Chemistries. On August 1, 2011, its Minntech Corporation subsidiary (Minntech) acquired the business and substantially all of the assets of Byrne Medical, Inc. On February 11, 2011, its Crosstex International, Inc. subsidiary (Crosstex) acquired the sterilization monitoring business of ConFirm Monitoring Systems, Inc. During the fiscal year ended July 31, 2011, it acquired the United States water purification business of Gambro Renal Products Inc. On August 1, 2011, it changed the name of its Endoscope Reprocessing operating segment to Endoscopy. On August 1, 2011, it acquired a 59,500 square-foot building in Conroe, Texas used for manufacturing, warehousing and administrative, sales and other staff.

More Posts by this author

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...